Clinical Trial

Telerehabilitation for Aphasia (TERRA)

Study acronym: TERRA
Recruiting
View on ClinicalTrials.gov →
Summary
Speech-language therapy is generally found to be helpful in the rehabilitation of aphasia. However, not all patients with aphasia have access to adequate treatment to maximize their recovery. The goal of this project is to compare the efficacy of telerehabilitation or Aphasia Remote Therapy (ART) to the more traditional In-Clinic Therapy (I-CT).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-12-18; most recent amendment 2026-04-01.
Status change: Not Yet Recruiting → Recruiting 2021-03-22
Trial Details
NCT Number NCT04682223
Lead Sponsor University of South Carolina
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD), Medical University of South Carolina
Conditions Aphasia, Stroke, Stroke Rehabilitation
Enrollment 100 participants
Start Date 2021-05-05
Primary Completion 2027-01 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-02